{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:19:36Z","timestamp":1768281576655,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"American College of Allergy, Asthma, and Immunology Young Investigator"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.anai.2018.03.006","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T13:15:24Z","timestamp":1521378924000},"page":"527-531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["A randomized, double-blinded, placebo-controlled study of the use of viscous oral cromolyn sodium for the treatment of eosinophilic esophagitis"],"prefix":"10.1016","volume":"120","author":[{"given":"Jay Adam","family":"Lieberman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Whitworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cary","family":"Cavender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2018.03.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.02.040","article-title":"Eosinophilic esophagitis: updated consensus recommendations for children and adults","volume":"128","author":"Liacouras","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.03.006_bib0015","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cgh.2009.06.023","article-title":"Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota","volume":"7","author":"Prasad","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.anai.2018.03.006_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MPG.0b013e3181788282","article-title":"14 years of eosinophilic esophagitis: clinical features and prognosis","volume":"48","author":"Spergel","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.anai.2018.03.006_bib0025","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.cgh.2008.02.003","article-title":"Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients","volume":"6","author":"Straumann","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.anai.2018.03.006_bib0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaci.2011.05.006","article-title":"Long-term outcomes in pediatric-onset esophageal eosinophilia","volume":"128","author":"DeBrosse","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.03.006_bib0035","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0016-5085(95)90637-1","article-title":"Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula","volume":"109","author":"Kelly","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anai.2018.03.006_bib0040","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2014.02.006","article-title":"Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis","volume":"146","author":"Arias","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anai.2018.03.006_bib0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.anai.2015.03.014","article-title":"Pharmacotherapy for eosinophilic esophagitis","volume":"114","author":"Lieberman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2018.03.006_bib0050","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1111\/j.1572-0241.2008.01989.x","article-title":"3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults","volume":"103","author":"Helou","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.anai.2018.03.006_bib0055","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1007\/s10620-011-1775-y","article-title":"Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis","volume":"56","author":"Lucendo","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.anai.2018.03.006_bib0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cgh.2016.09.013","article-title":"Montelukast does not maintain symptom remission after topical steroid therapy for eosinophilic esophagitis","volume":"15","author":"Alexander","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.anai.2018.03.006_bib0065","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S1542-3565(05)00885-2","article-title":"Eosinophilic esophagitis: a 10-year experience in 381 children","volume":"3","author":"Liacouras","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.anai.2018.03.006_bib0070","series-title":"Chapter 90. The Chromones: Cromolyn Sodium and Nedocromil Sodium","author":"Edwards","year":"2009"},{"key":"10.1016\/j.anai.2018.03.006_bib0075","series-title":"Gastrocrom Package Insert","author":"Celltech Pharmaceuticals, Inc.","year":"2006"},{"key":"10.1016\/j.anai.2018.03.006_bib0080","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaci.2010.08.050","article-title":"Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction","volume":"126","author":"Aceves","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.03.006_bib0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0091-6749(84)90085-X","article-title":"Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement","volume":"74","author":"Diaz","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.03.006_bib0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mai.2003.1500","article-title":"Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone propionate, and disodium cromoglycate","volume":"112","author":"Lindqvist","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.03.006_bib0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MPG.0b013e31817f0197","article-title":"Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis","volume":"48","author":"Pentiuk","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.anai.2018.03.006_bib0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MPG.0b013e31802c0d06","article-title":"Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease","volume":"44","author":"Kirsch","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.anai.2018.03.006_bib0105","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2559.2012.4303.x","article-title":"Atopic and non-atopic eosinophilic oesophagitis are distinguished by immunoglobulin E-bearing intraepithelial mast cells","volume":"61","author":"Mulder","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.anai.2018.03.006_bib0110","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.03.006_bib0115","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.04.049","article-title":"Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis","volume":"143","author":"Dellon","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anai.2018.03.006_bib0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/MPG.0000000000000436","article-title":"Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children","volume":"59","author":"Rubinstein","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.anai.2018.03.006_bib0125","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1007\/s10620-015-3990-4","article-title":"A randomized controlled comparison of esophageal clearance times of oral budesonide preparations","volume":"61","author":"Hefner","year":"2016","journal-title":"Dig Dis Sci"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618301662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618301662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:19:31Z","timestamp":1761052771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120618301662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1081120618301662"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2018.03.006","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized, double-blinded, placebo-controlled study of the use of viscous oral cromolyn sodium for the treatment of eosinophilic esophagitis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2018.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}